The proud partner of Frontiers Health 2020 and the host of the local Lausanne hub, Debiopharm, is hosting an exhaustive session on AI & Digital Clinical Trials (held on November 12th, 5:30 CET).
2 hours of the session will be dedicated to the digital transformation of clinical trials which is has acquired even more importance with the COVID-19 pandemic interrupting around 70% of ongoing clinical trials. The speakers will cover such elements of digital trials as virtual clinical trials (VCT), in silico trials, RWD control arms and AI enabled patient stratifications.
The session will be moderated by Tanja Dowe, CEO of Debiopharm Innovation Fund, and involves the top line-up of expert speakers presenting on the following topics:
-In silico clinical trials by Francois-Henri Boissel, CEO Novadiscovery
-RWD for synthetic control arms by Madelyn Trupkin Herzfeld, CEO Carevive
-Patient experience data in clinical trials & Digital endpoints, by Shibeshih Belachew, Vice President, Personalising Health Research, Analytics and Solutions, Worldwide Medical at Biogen
-Unlocking spatial biology using AI for better patient stratification by Avi Veidman, CEO NucleAI, Israel
-Patient recruitment by Petteri Kolehmainen, CEO Make Helsinki, Finland
At the end of the session all the panelists will be involved into the live discussion on the subject.
Join the session from Lausanne Local Hub to learn about all newest achievements and tendencies in digital trials!
